v3.26.1
Business Segment: (Tables)
6 Months Ended
Jun. 30, 2026
Business Segment:  
Schedule of disaggregated amounts that comprise research and development expenses

For the Three Months Ended June 30, 

For the Six Months Ended June 30, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

External clinical development expenses

$

10,353

$

84,457

$

20,704

$

110,648

Personnel related and stock-based compensation

 

7,013

 

44,258

 

9,525

 

57,083

Other research and development expenses

 

14,489

 

19,840

 

30,226

 

41,640

Total research and development expenses

$

31,855

$

148,555

$

60,455

$

209,371